PlainRecalls
FDA Drug Moderate Class II Terminated

METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-2932-01

Reported: May 21, 2014 Initiated: March 24, 2014 #D1292-2014

Product Description

METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-2932-01

Reason for Recall

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
22820 bottles
Distribution
Nationwide
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-2932-01. Recalled by Teva Pharmaceuticals USA. Units affected: 22820 bottles.
Why was this product recalled?
CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
Which agency issued this recall?
This recall was issued by the FDA Drug on May 21, 2014. Severity: Moderate. Recall number: D1292-2014.